FDA — authorised 29 March 2024
- Application: NDA218037
- Marketing authorisation holder: ALEXION PHARMS INC
- Local brand name: VOYDEYA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 DANICOPAN in United States
FDA authorised DANICOPAN on 29 March 2024
Marketing authorisation
DANICOPAN in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is DANICOPAN approved in United States?
Yes. FDA authorised it on 29 March 2024.
Who is the marketing authorisation holder for DANICOPAN in United States?
ALEXION PHARMS INC holds the US marketing authorisation.